Brief: Theravance Biopharma - Theravance And Mylan Enter Settlement Agreement With Eugia - SEC Filing
06/06/2025 12:12
Theravance Biopharma Inc TBPH.O: THERAVANCE BIOPHARMA - THERAVANCE AND MYLAN ENTER SETTLEMENT AGREEMENT WITH EUGIA - SEC FILING THERAVANCE BIOPHARMA INC - SETTLEMENT RESOLVES PATENT LITIGATION AGAINST EUGIA - SEC FILING THERAVANCE BIOPHARMA INC - EUGIA GRANTED LICENSE TO MARKET GENERIC YUPELRI FROM APRIL 23, 2039 - SEC FILING Source text: [ID:n0001104659-25-056996] Further company coverage: TBPH.O
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions